APS have been shown to restore cytokine balance within the tumour microenvironment and downregulate FOXP3 mRNA expression, thereby attenuating the immunosuppressive activity of CD4+CD25+ Tregs. The gene discussed is FOXP3; the disease is autoimmune polyendocrinopathy.